Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p

Jiakang Zhang, Takuya Furuta, Hemragul Sabit, Sho Tamai, Shabierjiang Jiapaer, Yu Dong, Masashi Kinoshita, Yasuo Uchida, Sumio Ohtsuki, Tetsuya Terasaki, Shiguang Zhao, Mitsutoshi Nakada

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have previously shown that gelsolin (GSN) levels are significantly lower in the blood of patients with glioblastoma (GBM) than in healthy controls. Here, we analyzed the function of GSN in GBM and examined its clinical significance. Furthermore, microRNAs involved in GSN expression were also identified. The expression of GSN was determined using western blot analysis and found to be significantly lower in GBM samples than normal ones. Gelsolin was mainly localized in normal astrocytes, shown using immunohistochemistry and immunofluorescence. Higher expression of GSN was correlated with more prolonged progression-free survival and overall survival. Gelsolin knockdown using siRNA and shRNA markedly accelerated cell proliferation and invasion in GBM in vitro and in vivo. The inactive form of glycogen synthase kinase-3β was dephosphorylated by GSN knockdown. In GBM tissues, the expression of GSN and microRNA (miR)-654-5p and miR-450b-5p showed an inverse correlation. The miR-654-5p and miR-450b-5p inhibitors enhanced GSN expression, resulting in reduced proliferation and invasion. In conclusion, GSN, which inhibits cell proliferation and invasion, is suppressed by miR-654-5p and miR-450b-5p in GBM, suggesting that these miRNAs can be targets for treating GBM.

Original languageEnglish
Pages (from-to)2413-2422
Number of pages10
JournalCancer science
Volume111
Issue number7
DOIs
Publication statusPublished - 2020 Jul 1

Keywords

  • GSK3β
  • gelsolin
  • glioblastoma
  • miR-450b-5p
  • miR-654-5p

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p'. Together they form a unique fingerprint.

  • Cite this

    Zhang, J., Furuta, T., Sabit, H., Tamai, S., Jiapaer, S., Dong, Y., Kinoshita, M., Uchida, Y., Ohtsuki, S., Terasaki, T., Zhao, S., & Nakada, M. (2020). Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p. Cancer science, 111(7), 2413-2422. https://doi.org/10.1111/cas.14429